CN102940671A - 治疗糖尿病足的药物组合物 - Google Patents
治疗糖尿病足的药物组合物 Download PDFInfo
- Publication number
- CN102940671A CN102940671A CN2012104285858A CN201210428585A CN102940671A CN 102940671 A CN102940671 A CN 102940671A CN 2012104285858 A CN2012104285858 A CN 2012104285858A CN 201210428585 A CN201210428585 A CN 201210428585A CN 102940671 A CN102940671 A CN 102940671A
- Authority
- CN
- China
- Prior art keywords
- parts
- diabetic foot
- medicine
- angelicae dahuricae
- nidus vespae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 208000008960 Diabetic foot Diseases 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title claims description 22
- 239000008194 pharmaceutical composition Substances 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 10
- 241000533849 Gleditsia Species 0.000 claims description 9
- 241000545442 Radix Species 0.000 claims description 7
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000005469 granulation Methods 0.000 description 14
- 230000003179 granulation Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 238000001035 drying Methods 0.000 description 8
- 239000012467 final product Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 238000002266 amputation Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010012665 Diabetic gangrene Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000005736 Nervous System Malformations Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- -1 hydroxypropyl Chemical group 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210428585.8A CN102940671B (zh) | 2012-10-31 | 2012-10-31 | 治疗糖尿病足的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210428585.8A CN102940671B (zh) | 2012-10-31 | 2012-10-31 | 治疗糖尿病足的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102940671A true CN102940671A (zh) | 2013-02-27 |
CN102940671B CN102940671B (zh) | 2014-10-29 |
Family
ID=47723731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210428585.8A Expired - Fee Related CN102940671B (zh) | 2012-10-31 | 2012-10-31 | 治疗糖尿病足的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102940671B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104436022A (zh) * | 2014-11-11 | 2015-03-25 | 成都华熹科技有限公司 | 一种含苦金盆的治疗糖尿病的中药组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1907394A (zh) * | 2005-08-03 | 2007-02-07 | 张成琼 | 一种治疗糖尿病足的药物 |
-
2012
- 2012-10-31 CN CN201210428585.8A patent/CN102940671B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1907394A (zh) * | 2005-08-03 | 2007-02-07 | 张成琼 | 一种治疗糖尿病足的药物 |
Non-Patent Citations (1)
Title |
---|
原焕勇: "中西医结合治疗糖尿病足疗效观察", 《辽宁中医杂志》, vol. 34, no. 08, 18 August 2007 (2007-08-18) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104436022A (zh) * | 2014-11-11 | 2015-03-25 | 成都华熹科技有限公司 | 一种含苦金盆的治疗糖尿病的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102940671B (zh) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108524673A (zh) | 一种中药组合物及其应用 | |
CN1247231C (zh) | 一种产后补血保健药物及其制备方法和应用 | |
CN1907394B (zh) | 一种治疗糖尿病足的药物 | |
CN102940693B (zh) | 治疗糖尿病足的药物组合物 | |
CN102940757B (zh) | 治疗糖尿病足的药物组合物 | |
CN101229345B (zh) | 益气补血药 | |
CN102940677B (zh) | 治疗糖尿病足的药物组合物 | |
CN106109564A (zh) | 治疗脑血栓的药物组合物及其制备方法 | |
CN1817354A (zh) | 辛芪注射剂及制备方法 | |
CN102940743B (zh) | 治疗糖尿病足的药物组合物 | |
CN102940671B (zh) | 治疗糖尿病足的药物组合物 | |
CN107468857A (zh) | 一种能够治疗胃溃疡的中药制备方法 | |
CN103798472B (zh) | 一种保健茶及保健养生制剂 | |
CN103181945B (zh) | 丝瓜子的用途 | |
CN102274428B (zh) | 一种具有治疗肠易激综合症作用的药物组合物及其制备方法和应用 | |
CN101450189A (zh) | 一种治疗心脑血管疾病的药物及其制备方法 | |
CN1726938A (zh) | 一种用于糖尿病足的保健搽洗剂及其制备方法和应用 | |
CN110339323A (zh) | 一种治疗心动过缓的中药组合物及其制备方法和应用 | |
CN104095915A (zh) | 一种治疗糖尿病足的中药组合物 | |
CN104435167A (zh) | 一种含有土元的治疗糖尿病足的中药组合物 | |
CN108743885A (zh) | 一种治疗糖尿病大血管病变的中药及其制备方法 | |
CN101391045B (zh) | 一种治疗偏正头痛的中药复方制剂及其制备方法 | |
CN104435497A (zh) | 一种治疗糖尿病足的中药组合物 | |
CN106581468A (zh) | 一种能够治疗胃溃疡的中药制备方法 | |
CN109420039A (zh) | 一种治疗糖尿病合并低血糖的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130227 Assignee: CHENGDU HUAXI TECHNOLOGY Co.,Ltd. Assignor: CHENGDU YILUKANG MEDICAL TECHNOLOGY & SERVICE Co.,Ltd. Contract record no.: 2015510000006 Denomination of invention: Medicine composition for treating diabetic foot Granted publication date: 20141029 License type: Exclusive License Record date: 20150205 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141029 |